Bluesight Trends Report Reveals Quicker Diversion Investigations and
Bluesight Trends Report Reveals Quicker Diversion Investigations and
New research provides insights into waste events, reduced hospital variances and improved investigations. ALEXANDRIA,…
![](https://bluesight.com/wp-content/uploads/2022/11/cropped-Bluesight-favicon-150x150.png)
Bluesight Appoints Jason Vander Meer as Chief Product Officer to Expand Medication Intelligence Suite
ALEXANDRIA, Va., Oct. 26, 2023 — Bluesight, the leader in Medication Intelligence™ solutions, announced today…
![](https://bluesight.com/wp-content/uploads/2022/11/cropped-Bluesight-favicon-150x150.png)
Thoma Bravo Announces Strategic Growth Investment in Bluesight to Support the Company’s Acquisition of Medacist
ALEXANDRIA, VA, CHESHIRE, CT, AND SAN FRANCISCO, CA July 17, 2023 –Thoma Bravo, a leading…
![](https://bluesight.com/wp-content/uploads/2021/03/kendal-L4iKccAChOc-unsplash-1.jpg)
Recent KLAS Research Points to CostCheck™ as a Market Leader in Pharmacy Purchasing Optimization
Recent KLAS Research Points to CostCheck™ as a Market Leader in Pharmacy Purchasing Optimization Leading…
![](https://bluesight.com/wp-content/uploads/2023/02/Blog-Banner_Diversion-Symposium_v1-150x150.png)
Bluesight Hosts Third Diversion Symposium to Explore Key Topics Related to Drug Diversion Prevention
ALEXANDRIA, Va.– On March 22nd, 2023 from 12 pm ET to 3pm ET, BluesightⓇ, The…
![](https://bluesight.com/wp-content/uploads/2022/10/LOGO_Diversion_Collective-150x150.png)
Bluesight for Controlled Substances launching the Diversion Collective, a New Educational Resource for Successful Diversion Prevention Programs.
Bluesight for Controlled Substances launching the Diversion Collective, a New Educational Resource for Successful Diversion…
![](https://bluesight.com/wp-content/uploads/2022/10/KitCheck_1000_Hospitals-150x150.png)
Kit Check Celebrates 1,000 Hospital Customer Milestone
The leading Medication Intelligence company has interacted with about 25% of acute and childrens’ hospitals…
![Syringe](https://bluesight.com/wp-content/uploads/2021/07/sam-moqadam-2rrsfMN4hn8-unsplash-150x150.jpg)
Kit Check Partners with Genixus™ to Introduce RFID-Tagged Propofol as the First Product Within the KinetiX™ Line of Ready-to-Administer Syringes
ALEXANDRIA, Va.–(BUSINESS WIRE)–Kit Check, the leading automation vendor in Medication Intelligence™, today announced that its…
![](https://bluesight.com/wp-content/uploads/2022/06/Diversion-Trends-Report_2022_Cover-1-150x150.png)
Kit Check’s Diversion Trends Report Reveals 8% of Controlled Substance Transactions in Hospitals Had Discrepancies Indicative of Potential Drug Diversion
Kit Check, the industry leader in Medication Intelligence™ solutions for hospitals, today announced the findings…
![](https://bluesight.com/wp-content/uploads/2022/03/Kit-Check_2021-Cover-150x150.png)
Kit Check Hospital Pharmacy Operations Report Reveals For The Fourth Consecutive Year Drug Shortages are the #1 Challenge Facing Hospital Pharmacies.
Report shows COVID-19 related issues such as drug shortages and staffing issues still remain a…